Noemi Reguart/X
Mar 30, 2025, 09:25
Noemi Reguart: Pembrolizumab and cCRT in unresectable LA NSCLC – Final KN-799
Noemi Reguart, Medical Oncologist at Hospital Clinic Barcelona, shared a post on X:
“Pembro + cCRT in unresectable LA NSCLC – Final KN-799:
– ORR >70% (across histologies)!
– mPFS 29 and 45 mo,
– mOS 36 and 57 mo (cohort A NSCLC, B NSQ).
– Sharp discussion S. Ramella.
– UNKNOWNS: impact of RT modality and immune response.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 1, 2025, 19:24
Aug 1, 2025, 19:14
Aug 1, 2025, 18:32